Search

Willie J. Daniel Jr.

Examiner (ID: 12204, Phone: (571)272-7907 , Office: P/2462 )

Most Active Art Unit
2462
Art Unit(s)
2462, 2465, 2641, 2617, 2686
Total Applications
889
Issued Applications
433
Pending Applications
99
Abandoned Applications
374

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16791559 [patent_doc_number] => 20210121376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-29 [patent_title] => PEPTIDES ENCAPSULATED IN LECITHIN AND ALGINATE [patent_app_type] => utility [patent_app_number] => 17/057142 [patent_app_country] => US [patent_app_date] => 2019-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8277 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057142 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/057142
PEPTIDES ENCAPSULATED IN LECITHIN AND ALGINATE May 20, 2019 Abandoned
Array ( [id] => 16686715 [patent_doc_number] => 20210069190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-11 [patent_title] => PHARMACEUTICAL COMPOSITION COMPRISING SMALL MOLECULE EGFR INHIBITOR AND PREPARATION METHOD THEREFOR [patent_app_type] => utility [patent_app_number] => 17/053605 [patent_app_country] => US [patent_app_date] => 2019-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6312 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17053605 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/053605
PHARMACEUTICAL COMPOSITION COMPRISING SMALL MOLECULE EGFR INHIBITOR AND PREPARATION METHOD THEREFOR May 12, 2019 Abandoned
Array ( [id] => 14712779 [patent_doc_number] => 20190247453 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => Transdermal Delivery of Cannabidiol with Other Active Moieties Including Cannabinoids [patent_app_type] => utility [patent_app_number] => 16/397322 [patent_app_country] => US [patent_app_date] => 2019-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11696 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 143 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16397322 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/397322
Transdermal delivery of cannabidiol with other active moieties including cannabinoids Apr 28, 2019 Issued
Array ( [id] => 15035311 [patent_doc_number] => 20190328660 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => NANOBUBBLES IN AN ABSORBENT MATERIAL [patent_app_type] => utility [patent_app_number] => 16/394430 [patent_app_country] => US [patent_app_date] => 2019-04-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8358 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16394430 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/394430
NANOBUBBLES IN AN ABSORBENT MATERIAL Apr 24, 2019 Abandoned
Array ( [id] => 14712485 [patent_doc_number] => 20190247306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-15 [patent_title] => ARTICLES AND METHODS OF TREATING VASCULAR CONDITIONS [patent_app_type] => utility [patent_app_number] => 16/393378 [patent_app_country] => US [patent_app_date] => 2019-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13271 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 114 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16393378 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/393378
ARTICLES AND METHODS OF TREATING VASCULAR CONDITIONS Apr 23, 2019 Abandoned
Array ( [id] => 15020651 [patent_doc_number] => 20190321330 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-24 [patent_title] => CANNABIS PLACEBO COMPOSITIONS, DELIVERY VEHICLES AND A METHOD FOR COLOUR MATCHING/NEUTRALIZATION OF CANNABIS PRODUCTS [patent_app_type] => utility [patent_app_number] => 16/388222 [patent_app_country] => US [patent_app_date] => 2019-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18471 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16388222 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/388222
CANNABIS PLACEBO COMPOSITIONS, DELIVERY VEHICLES AND A METHOD FOR COLOUR MATCHING/NEUTRALIZATION OF CANNABIS PRODUCTS Apr 17, 2019 Abandoned
Array ( [id] => 16612027 [patent_doc_number] => 20210030680 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-02-04 [patent_title] => NANOPARTICLE COMPOSITIONS AND METHODS OF USE OF PARP INHIBITOR FOR TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 15/733741 [patent_app_country] => US [patent_app_date] => 2019-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4941 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15733741 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/733741
NANOPARTICLE COMPOSITIONS AND METHODS OF USE OF PARP INHIBITOR FOR TREATMENT OF CANCER Apr 14, 2019 Abandoned
Array ( [id] => 14682057 [patent_doc_number] => 20190240143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => Sustained Release Pharmaceutical Dosage Form of Entecavir [patent_app_type] => utility [patent_app_number] => 16/382921 [patent_app_country] => US [patent_app_date] => 2019-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7047 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16382921 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/382921
Sustained Release Pharmaceutical Dosage Form of Entecavir Apr 11, 2019 Abandoned
Array ( [id] => 16581344 [patent_doc_number] => 20210015746 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-21 [patent_title] => NICOTINE GEL [patent_app_type] => utility [patent_app_number] => 16/982741 [patent_app_country] => US [patent_app_date] => 2019-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13263 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982741 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/982741
NICOTINE GEL Apr 7, 2019 Abandoned
Array ( [id] => 15586889 [patent_doc_number] => 20200069979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => TOPICAL COMPOSITIONS AND METHODS OF MANUFACTURING THEM IN SPECIFICALLY TREATED STEEL VESSELS [patent_app_type] => utility [patent_app_number] => 16/377039 [patent_app_country] => US [patent_app_date] => 2019-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3722 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16377039 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/377039
TOPICAL COMPOSITIONS AND METHODS OF MANUFACTURING THEM IN SPECIFICALLY TREATED STEEL VESSELS Apr 4, 2019 Abandoned
Array ( [id] => 16598184 [patent_doc_number] => 20210024715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-28 [patent_title] => SPHERICAL MICROPARTICLES [patent_app_type] => utility [patent_app_number] => 17/045691 [patent_app_country] => US [patent_app_date] => 2019-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19250 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045691 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/045691
SPHERICAL MICROPARTICLES Apr 3, 2019 Abandoned
Array ( [id] => 14621437 [patent_doc_number] => 20190224086 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-25 [patent_title] => MICROCAPSULE COMPOSITIONS WITH IMPROVED DEPOSITION [patent_app_type] => utility [patent_app_number] => 16/371393 [patent_app_country] => US [patent_app_date] => 2019-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16970 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16371393 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/371393
MICROCAPSULE COMPOSITIONS WITH IMPROVED DEPOSITION Mar 31, 2019 Abandoned
Array ( [id] => 16726415 [patent_doc_number] => 20210093562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-01 [patent_title] => ORAL GUM FORMULATION AND FABRICATION PROCESS THEREOF [patent_app_type] => utility [patent_app_number] => 17/044598 [patent_app_country] => US [patent_app_date] => 2019-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14398 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044598 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/044598
ORAL GUM FORMULATION AND FABRICATION PROCESS THEREOF Mar 28, 2019 Abandoned
Array ( [id] => 14621735 [patent_doc_number] => 20190224235 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-07-25 [patent_title] => TREATMENT OF ENTERIC STRESS FROM HEAT AND INFECTION IN HUMANS AND ANIMALS BY SUPPLEMENTATION WITH ZINC AND BUTYRIC ACID [patent_app_type] => utility [patent_app_number] => 16/369844 [patent_app_country] => US [patent_app_date] => 2019-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5325 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16369844 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/369844
TREATMENT OF ENTERIC STRESS FROM HEAT AND INFECTION IN HUMANS AND ANIMALS BY SUPPLEMENTATION WITH ZINC AND BUTYRIC ACID Mar 28, 2019 Abandoned
Array ( [id] => 16569512 [patent_doc_number] => 20210008518 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-01-14 [patent_title] => PROCESS FOR PREPARING MICROCAPSULES WITH IMPROVED DEPOSITION [patent_app_type] => utility [patent_app_number] => 16/979937 [patent_app_country] => US [patent_app_date] => 2019-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6450 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 110 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16979937 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/979937
Process for preparing microcapsules with improved deposition Mar 24, 2019 Issued
Array ( [id] => 14833285 [patent_doc_number] => 20190275043 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-12 [patent_title] => SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR [patent_app_type] => utility [patent_app_number] => 16/353951 [patent_app_country] => US [patent_app_date] => 2019-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9469 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16353951 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/353951
SOLID DISPERSIONS OF A ERB2 (HER2) INHIBITOR Mar 13, 2019 Abandoned
Array ( [id] => 17821480 [patent_doc_number] => 11426403 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-08-30 [patent_title] => Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, and methods of making and using same [patent_app_type] => utility [patent_app_number] => 16/351058 [patent_app_country] => US [patent_app_date] => 2019-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 12 [patent_no_of_words] => 35735 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 142 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16351058 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/351058
Formulations of 4-methyl-5-(pyrazin-2-yl)-3H-1,2-dithiole-3-thione, and methods of making and using same Mar 11, 2019 Issued
Array ( [id] => 14833069 [patent_doc_number] => 20190274935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-12 [patent_title] => Antiperspirant/deodorant Composition [patent_app_type] => utility [patent_app_number] => 16/299341 [patent_app_country] => US [patent_app_date] => 2019-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6737 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16299341 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/299341
Antiperspirant/deodorant Composition Mar 11, 2019 Abandoned
Array ( [id] => 17670770 [patent_doc_number] => 20220183937 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => METHOD FOR IMPROVING THE PERFORMANCE OF A FRAGRANCE OR A FRAGRANCE MIXTURE [patent_app_type] => utility [patent_app_number] => 17/438064 [patent_app_country] => US [patent_app_date] => 2019-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34486 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17438064 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/438064
METHOD FOR IMPROVING THE PERFORMANCE OF A FRAGRANCE OR A FRAGRANCE MIXTURE Mar 10, 2019 Abandoned
Array ( [id] => 18301043 [patent_doc_number] => 11622928 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-11 [patent_title] => Organic compounds [patent_app_type] => utility [patent_app_number] => 16/971758 [patent_app_country] => US [patent_app_date] => 2019-03-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8917 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 86 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16971758 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/971758
Organic compounds Mar 6, 2019 Issued
Menu